We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > cPass kit

News List

GenScript Receives EUA for Use of cPass SARS-CoV-2 Neutralization Antibody Test americanpharmaceuticalreview
February 24, 2021
GenScript has received Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration's (FDA) Center for Biologics Evaluation and Research (CBER) for use of the cPass™ SARS-CoV-2 Neutralization Antibody Detection Kit in convalescent plasma ...
GenScript Files for EUA of Rapid SARS-CoV-2 Neutralization Antibody Detection Kit americanpharmaceuticalreview
June 15, 2020
GenScript Biotech announced the company has filed for Emergency Use Authorization (EUA) with the U.S. Food and Drug Administration (FDA) to market its cPass™ SARS-CoV-2 Neutralization Antibody Detection Kit.